Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONONOFU: Randomized Double-Blind Placebo-Controlled Trial of Lasmiditan for a Single Migraine Attack in Japanese Patients
jRCT2080224865Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lasmiditan in migraine, migraine with aura and migraine without aura (4 arms), sponsored by Eli Lilly and Company. Started Sep 2019; status: completed.
02
Drugs
lasmiditan
03
Conditions
migrainemigraine with auramigraine without aura
Beyond the preview
Go deeper on jRCT2080224865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224865.